Earnings History Data for Anavex Life Sciences Corp. (AVXL) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Anavex Life Sciences Corp.
ANAVEX LIFE SCIENCES CORP. is an emerging biopharmaceutical company engaged in the discovery and development of novel drug targets for the treatment of cancer and neurological diseases. The company's proprietary SIGMACEPTOR Discovery Platform involves the rational drug design of compounds that fulfill specific criteria based on unmet market needs and new scientific advances. Selected drug candidates demonstrate high, non-exclusive affinity for sigma receptors, which are involved in the modulation of multiple cellular biochemical signaling pathways.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06-08-2024 | PM | AVXL | Anavex Life Sciences Corp. | 556.94 | -0.14 | -0.15 | -0.14 | Anavex Life Sciences GAAP EPS of -$0.14 beats by $0.02 [8/6/2024 7:32 AM] |
6.82 | 0.37 (5.74%) |
6.53 | 0.08 (1.24%) |
3.25 - 10.45 | 1,086,254 | 1,740,000 | 1,917 | ||
| 09-05-2024 | PM | AVXL | Anavex Life Sciences Corp. | 315.31 | -0.13 | -0.13 | -0.17 | Anavex Life Sciences GAAP EPS of -$0.13 misses by $0.02 [5/9/2024 7:31 AM] |
3.87 | 0.16 (4.18%) |
3.75 | 0.04 (1.08%) |
3.25 - 10.45 | 703,677 | 990,000 | 1,235 | ||
| 07-02-2024 | PM | AVXL | Anavex Life Sciences Corp. | 439.98 | -0.11 | -0.15 | -0.17 | Anavex Life Sciences GAAP EPS of -$0.11 beats by $0.04 [2/7/2024 7:35 AM] |
5.58 | -0.21 (-3.63%) |
5.92 | 0.13 (2.25%) |
4.90 - 11.93 | 1,309,747 | 1,150,000 | 25,857 | ||
| 08-08-2023 | PM | AVXL | Anavex Life Sciences Corp. | 664.49 | -0.14 | -0.17 | -0.16 | Anavex Life Sciences GAAP EPS of -$0.14 beats by $0.03 [8/8/2023 7:41 AM] |
8.04 | 0.36 (4.62%) |
7.88 | 0.20 (2.60%) |
7.44 - 15.24 | 900,081 | 720,000 | 1,981 | ||
| 09-05-2023 | PM | 7:00 AM ET (May 9) |
AVXL | Anavex Life Sciences Corp. | 671.89 | -0.17 | -0.18 | -0.14 | Anavex Life Sciences GAAP EPS of -$0.17 beats by $0.01 [5/9/2023 7:34 AM] |
9.10 | 0.69 (8.15%) |
8.40 | -0.01 (-0.12%) |
7.13 - 15.24 | 1,049,032 | 890,000 | 4,723 | |
| 07-02-2023 | PM | 7:00 AM ET (Feb 7) |
AVXL | Anavex Life Sciences Corp. | 887.23 | -0.17 | -0.20 | -0.14 | Anavex Life Sciences GAAP EPS of -$0.17 beats by $0.02 [2/7/2023 7:02 AM] |
11.72 | 0.61 (5.49%) |
10.90 | -0.21 (-1.89%) |
7.13 - 15.24 | 1,688,254 | 1,160,000 | 14,630 | |
| 28-11-2022 | PM | 7:00 AM ET (Nov 28) |
AVXL | Anavex Life Sciences Corp. | 885.43 | -0.18 | -0.16 | -0.15 | Anavex Life Sciences GAAP EPS of -$0.18 misses by $0.01 [11/28/2022 7:01 AM] |
9.09 | -2.80 (-23.59%) |
12.52 | 0.63 (5.30%) |
7.13 - 21.30 | 4,072,520 | 1,130,000 | 22,930 | |
| 13-05-2021 | PM | 4:15 PM ET (May 13) |
AVXL | Anavex Life Sciences Corp. | 780.14 | -0.12 | -0.12 | -0.12 | Anavex Life Sciences EPS beats by $0.03 [5/13/2021 7:11 AM] |
10.18 | -0.15 (-1.45%) |
10.41 | 0.08 (0.77%) |
3.42 - 28.70 | 987,908 | 600,000 | 4,345 | |
| 11-02-2021 | PM | After the close (Feb 11) |
AVXL | Anavex Life Sciences Corp. | 944.18 | -0.12 | -0.09 | -0.12 | Anavex Life Sciences EPS in-line [2/11/2021 7:22 AM] |
12.72 | -0.95 (-6.95%) |
13.00 | -0.67 (-4.90%) |
2.20 - 28.70 | 2,877,128 | 17,248,920 | 153,688 | |
| 28-12-2020 | PM | After the close (Dec 28) |
AVXL | Anavex Life Sciences Corp. | 352.12 | -0.10 | -0.13 | -0.07 | Anavex Life Sciences EPS beats by $0.06 [12/28/2020 7:04 AM] |
5.64 | -0.11 (-1.91%) |
5.92 | 0.17 (2.96%) |
2.20 - 7.69 | 1,667,080 | 2,287,872 | 14,930 | |
| 06-08-2020 | PM | 7:00 AM ET (Aug 6) |
AVXL | Anavex Life Sciences Corp. | 253.55 | -0.11 | -0.14 | -0.14 | Anavex Life Sciences EPS beats by $0.03 [8/6/2020 7:11 AM] |
4.12 | -0.43 (-9.54%) |
4.96 | 0.41 (9.01%) |
2.20 - 6.31 | 2,243,166 | 545,292 | 152,091 | |
|
|
||||||||||||||||||